Numenos

Company Overview

Snapshot

Founded in January 2023 by Vitalay Fomin and Amit Weiss, Numenos operates with 11–50 employees. The company has raised $5M across one funding round from one investor. In January 2025, Numenos secured seed funding from TechAviv Founder Partners.

Business overview

Numenos is a techbio company that has developed a clinico-genomic foundation model. The company focuses on leveraging advanced technology within the healthcare sector, specifically targeting the Health Tech & Life Sciences industry.

Company Intelligence Q&A

When was Numenos founded?

Numenos was founded in January 2023.

Who are the founders of Numenos?

Numenos was founded by Vitalay Fomin, who serves as Co-founder & CEO, and Amit Weiss, who is the Co-founder & CTO.

What is Numenos' primary sector?

Numenos operates primarily in the Health Tech & Life Sciences sector.

What is Numenos' core technology?

Numenos has developed a clinico-genomic foundation model.